China Health Industries Holdings, Inc. (CHHE) Equity Average (2016 - 2024)
China Health Industries Holdings (CHHE) has disclosed Equity Average for 14 consecutive years, with -$2.3 million as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Equity Average fell 105.58% year-over-year to -$2.3 million, compared with a TTM value of -$2.3 million through Mar 2024, down 105.58%, and an annual FY2023 reading of $41.0 million, down 6.47% over the prior year.
- Equity Average was -$2.3 million for Q1 2024 at China Health Industries Holdings, down from $18.2 million in the prior quarter.
- Across five years, Equity Average topped out at $44.8 million in Q3 2021 and bottomed at -$2.3 million in Q1 2024.
- Average Equity Average over 5 years is $38.2 million, with a median of $41.3 million recorded in 2022.
- The sharpest move saw Equity Average rose 14.78% in 2020, then crashed 105.58% in 2024.
- Year by year, Equity Average stood at $43.2 million in 2020, then grew by 3.67% to $44.8 million in 2021, then dropped by 8.65% to $40.9 million in 2022, then plummeted by 55.54% to $18.2 million in 2023, then tumbled by 112.88% to -$2.3 million in 2024.
- Business Quant data shows Equity Average for CHHE at -$2.3 million in Q1 2024, $18.2 million in Q4 2023, and $38.9 million in Q3 2023.